ID

43778

Beschreibung

Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01382147

Link

https://clinicaltrials.gov/show/NCT01382147

Stichworte

Versionen (2)
  1. 07.03.16 07.03.16 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myeloid Leukemia NCT01382147

Englisch

Eligibility Acute Myeloid Leukemia NCT01382147

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with newly diagnosed aml (except acute promyelocytic leukemia) according to the who classification including patients with secondary aml and aml after preceding hematologic disorders
Beschreibung

aml de novo

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1515568
age 18 years or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
informed consent. before any study specific procedure including randomisation is done or before study medication is administered, the subject, or legally acceptable representative, must have given written informed consent for participation in the study.
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute promyelocytic leukemia (apl)
Beschreibung

APL

Datentyp

boolean

Alias
UMLS CUI [1]
C0023487
previous or concurrent malignancies other than aml
Beschreibung

previous or concurrent malignancies

Datentyp

boolean

Alias
UMLS CUI [1]
C2735088
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0205420
previous treatment with colony-stimulating factors, interleukins or interferons
Beschreibung

colony stimulating factor, interleukins or interferons

Datentyp

boolean

Alias
UMLS CUI [1]
C0009392
UMLS CUI [2]
C0021764
UMLS CUI [3]
C0021747
known hypersensitivity to escherichia coli derived products (e.g. filgrastim, humulin® insulin, l-asparaginase, humatrope® growth hormone, intron a®)
Beschreibung

hypersensitivity to escherichia coli derived products

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014834
antibody-based or cell-based immunotherapies
Beschreibung

immunotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0021083
respiratory insufficiency with po2 <60 mmhg
Beschreibung

respiratory insufficiency

Datentyp

boolean

Alias
UMLS CUI [1]
C0035229
UMLS CUI [2]
C0202155
heart failure nyha iii° or iv°
Beschreibung

heart failure

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
elevated creatinine >2.0 mg/dl
Beschreibung

creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
elevated bilirubin >2.0 mg/dl
Beschreibung

bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
pregnancy or lactation
Beschreibung

pregnancy or lactation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
females without adequate contraception
Beschreibung

contraception females

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C0086287
known hiv and/or hepatitis c infection
Beschreibung

hiv and/or hepatitis c

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0019196
severe neurologic or psychiatric disease
Beschreibung

severe neurologic or psychiatric disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
psychiatric, addictive, or any disorder, which compromises ability to give truly informed consent for participation in this study
Beschreibung

disorder limiting informed consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
concerns for subject's compliance with the protocol procedures
Beschreibung

compliance behavior

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
lack of willingness to record and circulate personal disease-related informations defined in the study protocol
Beschreibung

compliance behaviour

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT01382147

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
aml de novo
Item
patients with newly diagnosed aml (except acute promyelocytic leukemia) according to the who classification including patients with secondary aml and aml after preceding hematologic disorders
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
informed consent. before any study specific procedure including randomisation is done or before study medication is administered, the subject, or legally acceptable representative, must have given written informed consent for participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
APL
Item
acute promyelocytic leukemia (apl)
boolean
C0023487 (UMLS CUI [1])
previous or concurrent malignancies
Item
previous or concurrent malignancies other than aml
boolean
C2735088 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0205420 (UMLS CUI [2,2])
colony stimulating factor, interleukins or interferons
Item
previous treatment with colony-stimulating factors, interleukins or interferons
boolean
C0009392 (UMLS CUI [1])
C0021764 (UMLS CUI [2])
C0021747 (UMLS CUI [3])
hypersensitivity to escherichia coli derived products
Item
known hypersensitivity to escherichia coli derived products (e.g. filgrastim, humulin® insulin, l-asparaginase, humatrope® growth hormone, intron a®)
boolean
C0020517 (UMLS CUI [1,1])
C0014834 (UMLS CUI [1,2])
immunotherapy
Item
antibody-based or cell-based immunotherapies
boolean
C0021083 (UMLS CUI [1])
respiratory insufficiency
Item
respiratory insufficiency with po2 <60 mmhg
boolean
C0035229 (UMLS CUI [1])
C0202155 (UMLS CUI [2])
heart failure
Item
heart failure nyha iii° or iv°
boolean
C1275491 (UMLS CUI [1])
creatinine
Item
elevated creatinine >2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
elevated bilirubin >2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
contraception females
Item
females without adequate contraception
boolean
C0700589 (UMLS CUI [1])
C0086287 (UMLS CUI [2])
hiv and/or hepatitis c
Item
known hiv and/or hepatitis c infection
boolean
C0019682 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
severe neurologic or psychiatric disease
Item
severe neurologic or psychiatric disease
boolean
C0009488 (UMLS CUI [1])
disorder limiting informed consent
Item
psychiatric, addictive, or any disorder, which compromises ability to give truly informed consent for participation in this study
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
compliance behavior
Item
concerns for subject's compliance with the protocol procedures
boolean
C1321605 (UMLS CUI [1])
compliance behaviour
Item
lack of willingness to record and circulate personal disease-related informations defined in the study protocol
boolean
C1321605 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video